8.465
price down icon8.98%   -0.835
after-market 시간 외 거래: 8.51 0.045 +0.53%
loading
전일 마감가:
$9.30
열려 있는:
$9.23
하루 거래량:
1.18M
Relative Volume:
1.04
시가총액:
$832.71M
수익:
-
순이익/손실:
$-106.81M
주가수익비율:
-2.5561
EPS:
-3.3117
순현금흐름:
$-8.40M
1주 성능:
-5.10%
1개월 성능:
-3.37%
6개월 성능:
-20.29%
1년 성능:
-30.61%
1일 변동 폭
Value
$8.46
$9.3423
1주일 범위
Value
$8.46
$9.3423
52주 변동 폭
Value
$5.1501
$16.81

이뮤놈 Stock (IMNM) Company Profile

Name
명칭
Immunome Inc
Name
전화
610-321-3700
Name
주소
18702 N. CREEK PARKWAY, BOTHELL
Name
직원
131
Name
트위터
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
IMNM's Discussions on Twitter

IMNM을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
IMNM
Immunome Inc
8.465 832.71M 0 -106.81M -8.40M -3.3117
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

이뮤놈 Stock (IMNM) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-02 개시 Lake Street Buy
2024-11-08 개시 Stephens Overweight
2024-05-31 개시 Piper Sandler Overweight
2024-04-30 개시 JP Morgan Overweight
2024-04-15 개시 Guggenheim Buy
2024-01-29 개시 Leerink Partners Outperform
2023-12-19 개시 Wedbush Outperform
2021-10-29 개시 Cantor Fitzgerald Overweight
모두보기

이뮤놈 주식(IMNM)의 최신 뉴스

pulisher
Jun 16, 2025

Immunome (IMNM) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Jun 16, 2025
pulisher
Jun 15, 2025

Trend Tracker for (IMNM) - news.stocktradersdaily.com

Jun 15, 2025
pulisher
Jun 13, 2025

Immunome, Inc. (NASDAQ:IMNM) Stake Raised by Wealth Enhancement Advisory Services LLC - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Wall Street Analysts See a 158.17% Upside in Immunome (IMNM): Can the Stock Really Move This High? - sharewise

Jun 12, 2025
pulisher
Jun 12, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 14,328 Shares of Immunome, Inc. (NASDAQ:IMNM) - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Bank of America Corp DE Sells 44,020 Shares of Immunome, Inc. (NASDAQ:IMNM) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Immunome Elects New Directors at Annual Meeting - TipRanks

Jun 11, 2025
pulisher
Jun 09, 2025

Squarepoint Ops LLC Reduces Position in Immunome, Inc. (NASDAQ:IMNM) - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Immunome, Inc. (NASDAQ:IMNM) Shares Sold by Jane Street Group LLC - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 5, 2025 - BioSpace

Jun 06, 2025
pulisher
Jun 06, 2025

Lifesci Capital Has Bullish Outlook for Immunome Q2 Earnings - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 563 - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Immunome Reports Inducement Grants Under Nasdaq Listing Rule - MarketScreener

Jun 05, 2025
pulisher
Jun 05, 2025

Two Sigma Advisers LP Makes New $512,000 Investment in Immunome, Inc. (NASDAQ:IMNM) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Immunome, Inc. (NASDAQ:IMNM) Shares Sold by Nuveen Asset Management LLC - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Insider Buying: Jean Bienaime Acquires Additional Shares of Immu - GuruFocus

Jun 04, 2025
pulisher
Jun 03, 2025

14,477 Shares in Immunome, Inc. (NASDAQ:IMNM) Acquired by ProShare Advisors LLC - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Two Sigma Investments LP Purchases Shares of 154,467 Immunome, Inc. (NASDAQ:IMNM) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Millennium Management LLC Buys New Position in Immunome, Inc. (NASDAQ:IMNM) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

BNP Paribas Financial Markets Invests $70,000 in Immunome, Inc. (NASDAQ:IMNM) - Defense World

Jun 03, 2025
pulisher
May 30, 2025

Deutsche Bank AG Has $489,000 Stock Holdings in Immunome, Inc. (NASDAQ:IMNM) - Defense World

May 30, 2025
pulisher
May 27, 2025

Wall Street Analysts Think Immunome (IMNM) Could Surge 188.57%: Read This Before Placing a Bet - MSN

May 27, 2025
pulisher
May 25, 2025

Immunome, Inc. (NASDAQ:IMNM) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

May 25, 2025
pulisher
May 23, 2025

(IMNM) Trading Report - news.stocktradersdaily.com

May 23, 2025
pulisher
May 22, 2025

Immunome to Present at Upcoming Investor Conferences - BioSpace

May 22, 2025
pulisher
May 22, 2025

Cancer Therapy Developer Immunome Set for TD Cowen and Goldman Sachs Healthcare Conferences - Stock Titan

May 22, 2025
pulisher
May 21, 2025

Immunome, Inc. (NASDAQ:IMNM) Shares Acquired by Northern Trust Corp - Defense World

May 21, 2025
pulisher
May 20, 2025

Immunome, Inc. Reports Q1 2025 Financial Results - TipRanks

May 20, 2025
pulisher
May 20, 2025

Immunome stock rating cut to Hold by Boral Capital - Investing.com Nigeria

May 20, 2025
pulisher
May 17, 2025

Immunome, Inc. (IMNM) Reports Q1 Loss, Tops Revenue Estimates - MSN

May 17, 2025
pulisher
May 16, 2025

Leerink Partnrs Has Strong Estimate for Immunome Q2 Earnings - Defense World

May 16, 2025
pulisher
May 15, 2025

Voya Investment Management LLC Has $166,000 Stock Position in Immunome, Inc. (NASDAQ:IMNM) - Defense World

May 15, 2025
pulisher
May 15, 2025

All You Need to Know About Immunome (IMNM) Rating Upgrade to Buy - MSN

May 15, 2025
pulisher
May 14, 2025

Immunome (NASDAQ:IMNM) Shares Gap Up Following Earnings Beat - Defense World

May 14, 2025
pulisher
May 14, 2025

Immunome First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 14, 2025
pulisher
May 13, 2025

Immunome (IMNM) Financial Update and Clinical Progress in Q1 202 - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Wedbush Adjusts Price Target on Immunome to $21 From $33, Maintains Outperform Rating - marketscreener.com

May 13, 2025
pulisher
May 12, 2025

(IMNM) Investment Report - news.stocktradersdaily.com

May 12, 2025
pulisher
May 12, 2025

Immunome Reports First Quarter 2025 Financial Results and Provides Business Update - BioSpace

May 12, 2025
pulisher
May 12, 2025

Immunome Inc (IMNM) Q1 2025 Earnings: EPS Loss of $0.52 Beats Es - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Immunome Q1 Income From Operations USD -44.636 Million - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

Immunome Expands Share Reserve in Inducement Plan - TipRanks

May 12, 2025
pulisher
May 12, 2025

Immunome Reports First Quarter 2025 Financial Results and Provides Business Update | IMNM Stock News - GuruFocus

May 12, 2025

이뮤놈 (IMNM) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

이뮤놈 주식 (IMNM) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Higgins Jack
Chief Scientific Officer
Mar 27 '25
Option Exercise
1.35
5,200
7,020
18,729
BIENAIME JEAN JACQUES
Director
Mar 25 '25
Buy
7.78
7,800
60,684
31,415
SIEGALL CLAY B
President and CEO
Mar 26 '25
Buy
7.29
137,100
999,459
806,736
BIENAIME JEAN JACQUES
Director
Mar 24 '25
Buy
8.21
7,000
57,470
23,615
Tsai Philip
Chief Technology Officer
Mar 24 '25
Buy
8.42
12,300
103,566
33,300
SIEGALL CLAY B
President and CEO
Jan 31 '25
Buy
7.75
150,000
1,162,500
669,636
SIEGALL CLAY B
President and CEO
Nov 21 '24
Buy
9.54
66,057
630,263
485,693
SIEGALL CLAY B
President and CEO
Nov 22 '24
Buy
9.78
33,943
331,918
519,636
Lechleider Robert
Chief Medical Officer
Nov 21 '24
Buy
9.48
15,805
149,800
15,805
Tsai Philip
Chief Technology Officer
Nov 21 '24
Buy
9.43
21,000
198,030
21,000
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
자본화:     |  볼륨(24시간):